Literature DB >> 10961907

A gene-anchored map position of the rat warfarin-resistance locus, Rw, and its orthologs in mice and humans.

M H Kohn1, H J Pelz.   

Abstract

The locus underlying hereditary resistance to the anticoagulant warfarin (symbol in the rat, Rw) was placed in relation to 8 positionally mapped gene-anchored microsatellite loci whose positions were known in the genome maps of the rat, mouse, and human. Rw segregated with the markers Myl2 (zero recombinants) and Itgam, Il4r, and Fgf2r (one recombinant each) during linkage analysis in a congenic warfarin- and bromadiolone-resistant laboratory strain of rats. Comparative ortholog mapping between rat, mouse, and human placed Rw onto mouse chromosome 7 at about 60 to 63 cM and onto one of the human chromosomes 10q25.3-26, 12q23-q24.3, and 16p13.1-p11. (Blood. 2000;96:1996-1998)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10961907

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Warfarin: a case history in pharmacogenetics.

Authors:  A M Hall; M R Wilkins
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

Review 2.  Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis.

Authors:  Martin J Shearer; Paul Newman
Journal:  J Lipid Res       Date:  2014-01-31       Impact factor: 5.922

3.  A cardiovascular phenotype in warfarin-resistant Vkorc1 mutant rats.

Authors:  Michael H Kohn; Roger E Price; Hans-Joachim Pelz
Journal:  Artery Res       Date:  2008-11       Impact factor: 0.597

4.  Locus-specific genetic differentiation at Rw among warfarin-resistant rat (Rattus norvegicus) populations.

Authors:  Michael H Kohn; Hans-Joachim Pelz; Robert K Wayne
Journal:  Genetics       Date:  2003-07       Impact factor: 4.562

Review 5.  Pharmacogenetics and anticoagulant therapy.

Authors:  Brian F Gage; Charles S Eby
Journal:  J Thromb Thrombolysis       Date:  2003 Aug-Oct       Impact factor: 2.300

6.  Consequences of the Y139F Vkorc1 mutation on resistance to AVKs: in-vivo investigation in a 7th generation of congenic Y139F strain of rats.

Authors:  Agnes Grandemange; Michael Hans Kohn; Romain Lasseur; Christiane Longin-Sauvageon; Philippe Berny; Etienne Benoit
Journal:  Pharmacogenet Genomics       Date:  2009-10       Impact factor: 2.089

7.  Identifying the genotype behind the phenotype: a role model found in VKORC1 and its association with warfarin dosing.

Authors:  Dana C Crawford; Marylyn D Ritchie; Mark J Rieder
Journal:  Pharmacogenomics       Date:  2007-05       Impact factor: 2.533

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.